DANIEL DESALVO to Young Adult
This is a "connection" page, showing publications DANIEL DESALVO has written about Young Adult.
Connection Strength
0.466
-
Real-World Insights Into Hypoglycemia Risk While Driving in Teens and Young Adults With Type 1 Diabetes. Pediatr Diabetes. 2025; 2025:5053872.
Score: 0.081
-
Transatlantic Comparison of Pediatric Continuous Glucose Monitoring Use in the Diabetes-Patienten-Verlaufsdokumentation Initiative and Type 1 Diabetes Exchange Quality Improvement Collaborative. Diabetes Technol Ther. 2022 12; 24(12):920-924.
Score: 0.068
-
Diabetes Device Use and Glycemic Control among Youth with Type 1 Diabetes: A Single-Center, Cross-Sectional Study. J Diabetes Res. 2018; 2018:5162162.
Score: 0.052
-
Effect of lipohypertrophy on accuracy of continuous glucose monitoring in patients with type 1 diabetes. Diabetes Care. 2015 Oct; 38(10):e166-7.
Score: 0.042
-
Remote glucose monitoring in camp setting reduces the risk of prolonged nocturnal hypoglycemia. Diabetes Technol Ther. 2014 01; 16(1):1-7.
Score: 0.037
-
Real-World Evidence of Omnipod? 5 Automated Insulin Delivery System Use in 69,902 People with Type 1 Diabetes. Diabetes Technol Ther. 2024 08; 26(8):514-525.
Score: 0.019
-
Continuous Glucose Monitoring Provides Durable Glycemic Benefit in Adolescents and Young Adults with Type 1 Diabetes: 12-Month Follow-Up Results. Pediatr Diabetes. 2023; 2023:6718115.
Score: 0.019
-
Adolescent- and Young Adult-Reported Outcomes and Use of Continuous Glucose Monitoring Features: A Report from the CITY Trial. Pediatr Diabetes. 2023; 2023:6906023.
Score: 0.018
-
Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes. Diabetes Care. 2021 07; 44(7):1630-1640.
Score: 0.016
-
Inequities in Diabetic Ketoacidosis Among Patients With Type 1 Diabetes and COVID-19: Data From 52 US Clinical Centers. J Clin Endocrinol Metab. 2021 03 25; 106(4):e1755-e1762.
Score: 0.015
-
Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial. JAMA. 2020 06 16; 323(23):2388-2396.
Score: 0.015
-
Characteristics of adult- compared to childhood-onset type 1 diabetes. Diabet Med. 2020 12; 37(12):2109-2115.
Score: 0.015
-
The Transatlantic HbA1c gap: differences in glycaemic control across the lifespan between people included in the US T1D Exchange Registry and those included in the German/Austrian DPV registry. Diabet Med. 2020 05; 37(5):848-855.
Score: 0.014
-
Dyslipidaemia and statin use in individuals aged 10 to <40 years in the T1D Exchange clinic registry. Diabetes Obes Metab. 2019 01; 21(1):170-172.
Score: 0.013
-
Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial. Lancet. 2017 01 28; 389(10067):369-380.
Score: 0.012
-
Duration of Infusion Set Survival in Lipohypertrophy Versus Nonlipohypertrophied Tissue in Patients with Type 1 Diabetes. Diabetes Technol Ther. 2016 07; 18(7):429-35.
Score: 0.011
-
Effect of acetaminophen on CGM glucose in an outpatient setting. Diabetes Care. 2015 Oct; 38(10):e158-9.
Score: 0.010
-
Overnight glucose control with an automated, unified safety system in children and adolescents with type 1 diabetes at diabetes camp. Diabetes Care. 2014 Aug; 37(8):2310-6.
Score: 0.010